Optimizing ankle foot orthoses in neuromuscular diseases
Completed
- Conditions
- euromuscular diseases (neuromusculaire aandoeningen)calf muscle weakness (kuitspierzwakte)ankle foot orthosis, AFO (enkel voet orthese, EVO)gait pattern (gangpatroon)walking effort (energieverbruik)stiffness (stijfheid)
- Registration Number
- NL-OMON22379
- Lead Sponsor
- Academic Medical Center (AMC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 37
Inclusion Criteria
patients with non-spastic distal weakness of the calf muscles weakness (defined as an MRC score < 5 or unable to perform > 3 heel rises);
- age: between 18 and 80 years old;
Exclusion Criteria
- presence of pes equinus under weight-bearing (dorsiflexion < 0 degrees);
- severe deformity of the ankle/foot that cannot be fitted with an AFO;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be walking energy cost (in J/kg/m), which will be measured during a 6-minute walk test (6MWT) at comfortable speed with simultaneous gas-analysis. Gas-analysis will be measured using the portable Cosmed K4B2 system.
- Secondary Outcome Measures
Name Time Method